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Abstract 
The Amyotrophic lateral sclerosis (ALS) is
the most common form of motor neuron dis-
ease in the adulthood, and it is characterized
by rapid and progressive compromise of the
upper and lower motor neurons. The majority
of the cases of ALS are classified as sporadic
and, until now, a specific cause for these cases
still  is  unknown.  To  present  the  different
hypotheses on the etiology of ALS. It was car-
ried out a search in the databases: Bireme,
Scielo and Pubmed, in the period of 1987 to
2011,  using  the  following  keywords:
Amyotrophic  lateral  sclerosis,  motor  neuron
disease, etiology, causes and epidemiology and
its similar in Portuguese and Spanish. It did
not have consensus as regards the etiology of
ALS.  Researches  demonstrates  evidences  as
regards intoxication by heavy metals, environ-
mental and occupational causes, genetic muta-
tions (superoxide dismutase 1), certain viral
infections and the accomplishment of vigorous
physical activity for the development of the dis-
ease. There is still no consensus regarding the
involved factors in the etiology of ALS. In this
way, new research about these etiologies are
necessary,  for  a  better  approach  of  the
patients,  promoting  preventive  programs  for
the disease and improving the quality of life of
the patients.
Introduction
Amyotrophic lateral sclerosis (ALS) is the
most common form of motor neuron disease in
adulthood and it is characterized by progres-
sive  and  degenerative  compromise  of  the
upper and lower motor neurons,1,2 resulting in
progressive  amyotrophy,  fasciculations,  pare-
sis, and spasticity.3Respiratory muscles failure
is generally the fatal event, occurring in 1-5
years after the first manifestations of the dis-
ease.4 Its incidence is 1-3 cases/100,000 inhab-
itants,  and  its  prevalence  is  3-5/100,000.
However, some areas in the Western Pacific
(Guam  Island,  Kii  Peninsula  in  Japan  and
Western  New  Guinea)  present  prevalence
around 50 times higher.2,5 Most ALS cases are
classified  as  sporadic,  while  in  around  5%
there  is  evidence  of  family  history  (familial
ALS). Commonly these cases show Mendelian
autosomal  dominant  inheritance.  However,
autosomal recessive patterns have also been
identified.1 Clinically and pathologically, spo-
radic  and  familial  forms  are  similar,  which
suggests a common pathogenesis.6 No specific
cause for most cases is known yet and unfortu-
nately, up to this moment, there is no medica-
tion to interrupt the course of the disease.7,8
Taking  into  consideration  the  difference  in
prevalence in distinct parts of the world, the
absence of a defined inheritance pattern and a
high prevalence of ALS in particular familial
nuclei, the cause of this disease is not accu-
rately known. The objective of this study is to
present,  based  on  literature,  the  different
hypotheses on ALS’s etiology.
Materials and Methods  
This review article used articles in the data
bases Bireme, Scielo and Pubmed, using the
following  keywords:  Amyotrophic  Lateral
Sclerosis,  motor  neuron  disease,  etiology,
causes and epidemiology, and their correspon-
dents in Portuguese and Spanish, in the peri-
od of 1987-2011.  
Literature review
Genetic mutations 
In 1993, Rosen et al.9described mutations in
the codification of the gene superoxide dismu-
tase 1 (SOD1), which catalyses the dismuta-
tion of the superoxide radical into hydrogen
and oxygen peroxide. SOD1 is a cytoplasmatic
enzyme dependent on copper and zinc. There
are  more  than  100  different  mutations  of
SOD1, the most common being the substitu-
tion of valine with alanine in position 4 (A4V),
most of which are dominant, except for the
substitution of alanine with aspartate in posi-
tion  90  (D90A),  which  can  be  recessive  or
dominant. Dominant mutations are believed to
act with a toxic gain of function as the result of
an abnormal accumulation of products of the
protein SOD1.2,10,11 SOD1’s toxicity suggests
an oxidative damage, and an SOD1 mutation
may  increase  motoneurons’  vulnerability,
inhibiting  the  activity  of  certain  proteins,
mainly in cases of familial ALS. Intracellular
aggregation may limit mitochondrial function
and  disorganize  neurofilamental  structure,
which can activate apoptotic factors and inhib-
it axonal transportation, respectively. In addi-
tion, similar damages to astrocytes may inter-
rupt glutamatergic neurotransmission, result-
ing  in  excitotoxicity,  with  resulting  cellular
death.3 Sporadic ALS differs from familial ALS
in some aspects. In sporadic ALS symptoms’
onset usually occur around the age of 55-65
years,  with  a  mean  of  64  years;  it  is  more
prevalent in men than in women (1.5:1), prob-
ably due a hormonal protection in women and
a greater exposure among men to supposed
risk factors; it also presents a mortality of 1.84
per 100,000 inhabitants.12 However, Orsini et
al.13 report 3 cases of sporadic ALS of juvenile
onset. In this series of cases, the age of the
individuals varied between 26-28 years, none
presented  family  history  of  the  disease.
Differently, in familial ALS the age of onset of
symptoms varies between 45-55 years, and the
prevalence  is  similar  between  men  and
women,  with  a  lower  life  expectancy.  Both
forms of the disease are similar in clinical and
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mutations found can be considered to act in
the predisposition to ALS, including one which
regulates  retrograde  axonal  transportation.8
Other  responsible  genes  for  familial  ALS
include alsin (ALS2),14,15 senataxin (ALS4),16
angiogenin,17 and a mutation in the subunit
p150 of dynactin (DCTN1).18,19 Despite numer-
ous researches on SOD1, this mutation can be
identified in around 20% of cases.9,20The other
80% of familial cases are related with genes
not yet known.  Sporadic ALS may possibly be
related to alterations in more complex genetic
systems, in which those would act more as risk
factors than as a direct cause for the disease.8
Due to the clinic similarity with the sporadic
form,  progresses  in  the  elucidation  of  the
mechanisms involved in the familial form may
favor researches in both forms of the disease.3
Currently,  mutations  in  the  FUS  gene  have
been described as the cause of familial ALS.21
Rademakers et al.22 developed a genetic analy-
sis of FUS in 200 ALS patients, 32 familial type
cases, and 168 sporadic. A mutation was iden-
tified in a familial case (p.R521C) and another
one in a sporadic case (p.G187S). This study
suggests that the phenotype with FUS muta-
tions goes beyond ALS classical form, indicat-
ing that there are clinical genetic correlations
specific  to  the  case.  TARDBP-  related  ALS
appears indistinguishable from ALS of other
known and unknown causes based on gender
ratio, age of onset, symptom distribution, and
severity  of  disease,  and  is  characterized  by
lower motor neuron (LMN) and upper motor
neuron (UMN) involvement. More than 80 per-
sons  with  TARDBP-  related  ALS  have  been
described in the literature. The spectrum of
the clinical aspects in these patients appears
to  overlap  significantly  with  idiopathic  and
SOD1-related ALS. It’s inherited in an autoso-
mal dominant manner. The proportion of cases
caused by new mutations is unknown. Each
child  of  an  individual  with  TARDBP-related
ALS has a 50% chance of inheriting the muta-
tion.23 The  diagnosis  is  established  when  a
pathogenic TARDBP mutation is identified in a
patient meeting clinical diagnostic criteria for
ALS. Spinal onset was reported in 77% of indi-
viduals  with  TARDBP  mutations  and  (LMN)
predominant  disease  was  seen  in  39%
[Kühnlein  et  al. 2008].  Frontotemporal
dementia  (FTD)and  cognitive  impairments
have  not  been  reported  in  individuals  with
TARDBP  mutations.24 After  discovery  the
mutations in the gene coding for the Cu/Zn
superoxide dismutase 1 (SOD1) in subsets of
familial  ALS  patients,  several  transgenic
mouse studies have been generated with vari-
ous forms of SOD1 mutants overexpressed at
different levels. Studies with these mice yield-
ed  complex  results  with  multiple  targets  of
damage  in  disease  including  mitochondria,
proteasomes,  and  secretory  pathways.
Evidence is emerging of a complex interaction
between genetic and molecular factors, with
resultant damage of critical target proteins and
organelles within the motor neuron. Results
revealed that neurofilament heavy subunit was
identified in 70% of ALS cases and conclude
that this subunit may be a promising biomark-
er for clinical diagnosis of ALS.25,26
Environmental and Occupational Causes 
The  possibility  of  environmental  factors
being involved in ALS etiology is due to varia-
tions in its incidence and to the fact that some
genetic and epidemiologic studies associate it
with  the  exposure  to  pesticides.27-29 In  this
context, the high prevalence of ALS cases in
the Guam region can be cited, when compared
with the rest of the world. In this region, a
complex  clinical  picture  constituted  by  ALS,
Parkinsonism  and  dementia  (ALS-PD  com-
plex)  occurred  in  the  Chamorro  population,
with prevalence around 50 times higher than
in the West.2,5 Three great theories were pro-
posed to justify the high incidence in this pop-
ulation: genetic, because of the familial aggre-
gation of ALS cases and ALS-PD complex; food
consumption of a neurotoxin from the plant
cycad; and exposure to potable water and culti-
vation  soils  with  low  calcium  and  high  alu-
minum.11 However, according to a new theory,
the high rates of amyotrophic lateral sclerosis
(ALS) on Guam may have been caused by the
native  people's  predilection  for  eating  bats.
Researchers proposed the theory based partly
on observations that the bats, a delicacy among
native Guamanians, eat poisonous nuts from
the cycad tree, a sort of palm tree indigenous
to the island.30 Actually, Beta-methyl-amino-L-
alanine, (BMAA), is found in multiple compo-
nents of the traditional Chamorro diet of Guam
and  this  confounds  epidemiological  analysis
based on a single dietary item. Recent discov-
eries  that  found  that  BMAA  is  produced  by
symbiotic  cyanobacteria  within  specialized
roots of the cycads; that the concentration of
protein-bound BMAA is up to a hundred-fold
greater than free BMAA in the seeds and flour;
that various animals forage on the seeds (fly-
ing foxes, pigs, deer), leading to biomagnifica-
tion up the food chain in Guam; and that pro-
tein-bound  BMAA  occurs  in  the  brains  of
Guamanians dying of ALS/PDC (average con-
centration 627 microg/g, 5 mM) but not in con-
trol brains have rekindled interest in BMAA as
a possible trigger for Guamanian ALS/PDC.31,32
Recent studies have demonstrated a decrease
in  the  incidence  of  ALS  and  ALS-PD  cases
throughout the last 40 years, despite the dis-
cretion  of  this  reduction  in  the  decades  of
1980-1990 with respect to the ALS-PD complex.
33-35In this population, it was observed that the
traditional diet included the ingestion of a type
of bat, the flying fox. However, this species,
due to its feeding habits, presents high con-
centrations  of  b-N-methylamino-L-alanine
(BMMA), a strong excitotoxic amino acid capa-
ble of damaging the motor cortex of monkeys’
brain.11,36 Some  occupations  or  exposures
seem related to the risk of ALS, including agri-
culture and the production of chemical prod-
ucts, exposure to electromagnetic fields, weld-
ing, labor or electric shocks. Aiming at assess-
ing the relation between occupational causes
and ALS mortality, Weisskopf et al.37 conducted
a study in the period of 1989-2002, in which a
questionnaire  concerning  the  occupation  of
participants was used; they quantified the total
of deaths during the period of the research. As
a result, they obtained an increase of mortality
among  men  who  worked  as  laboratory  pro-
grammers  and  technicians;  and,  among
women,  an  increase  in  mortality  among
machine setters and nurses. The authors high-
light that these results were based on a small
number of cases in each professional category
and that they must be interpreted with cau-
tion. In addition, for laboratory programmers
and technicians, the results were not consis-
tent between men and women, and this incon-
sistency might be due to men and women per-
forming different functions within a particular
work group, an aspect that was not investigat-
ed.  A  study  conducted  by  Morahan  et  al.38
investigated the action of environmental tox-
ins in the development of ALS in Australian
population. A total of 179 sporadic ALS patients
were  evaluated  through  a  questionnaire
addressing issues such as exposure to metals,
solvents or chemical products and residence in
rural areas. The evaluation pointed towards an
association of the disease with the exposure to
chemical products/solvents, as well as to herbi-
cides/pesticides, indicating that environmen-
tal toxins may be risk factors. Weisskopf et al.29
conducted  a  prospective  and  cross-sectional
study, in which they observed the association
between exposure to chemical agents and ALS
development, through the application of ques-
tionnaires evaluating the exposure to chemi-
cal agents throughout life, and identified the
number of deaths during the researched peri-
od (1989-2004). The study indicated small evi-
dence of association between exposure to pes-
ticides and herbicides and the emergence of
ALS. However, there was a greater evidence of
ALS  risk  with  exposure  to  formaldehyde.
Another  risk  factor  for  ALS  is  smoking.
Cigarettes contain toxic agents which induce
oxidative stress in the organism. As demon-
strated by Weisskopf et al.,39 who investigated
the  association  between  smoking  and  ALS
through questionnaires, there seems to be an
association  of  recent  smoking  with  the
increase in death due to ALS in women, but it
may be associated to other factors, including
hormonal factors or the use of contraceptives.
A study conducted by Fang et al.40 analyzed the
association between smoking, snuff dipping,
and the risk of ALS incidence in a group of
Article
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on smoking habits were applied and an inter-
view with each participant was performed to
obtain information on smoking and snuff dip-
ping.  From  the  results  no  increase  of  ALS
among  smoking  men  or  snuff  dippers  was
observed  when  compared  to  nonsmokers.
Sutedja et al.41 applied a questionnaire in 364
patients in order to investigate the independ-
ent effect of smoking, education and occupa-
tion in the development of ALS. The authors
concluded  that  all  assessed  aspects  are  risk
factors for ALS. Smokers, those with low edu-
cational  level  and  women  performing  craft-
work present a higher risk of developing the
disease. Smokers are also more likely to devel-
op ALS, and this was the only factor to present
an  independent  relation  with  ALS.  Popat  et
al.42 investigated another risk factor for ALS:
anti-inflammatory  medications.  They  per-
formed a controlled study, in which participat-
ed  3  million  members  of  the  Kaiser
Permenente  Medical  Care  Program,  in
Northern California in the period of 1996-2000.
It  was  observed  that  the  use  of  non-steroid
anti-inflammatory medications had no associ-
ation with ALS development, neither as a risk
factor, nor as a protective factor. However, in
the placebo group a difference between sexes
was observed, with a higher risk to men when
compared to women. Among the various spo-
radic forms, a number of risk factors and asso-
ciations have been linked to ALS development,
mainly  those  involving  traumas  (mechanic,
electric,  and/or  surgical).  A  recent  study
describes an ALS case subsequent to an elec-
tric trauma. The 25-year-old patient suffered
an intense electric shock when his left forearm
had contact with an uncovered wire. There was
no loss of consciousness, although small burn-
ings were evident. Within 1 year, the patient
reported muscular pains with involuntary con-
tractions in higher limbs. Afterwards, he devel-
oped muscular weakness and fatigue, predom-
inantly in the left hand in the beginning, with
further evolution to the right hand. No bulbar
muscular weakness was observed, neither of
the  musculature.  Several  complementary
exams were performed, resulting in ALS diag-
nosis.  However,  the  authors  suggested  that
this case may have occurred due to an interac-
tion  between  genetic  factors  (SOD1  muta-
tions)  and  environmental  factors  (electric
shock).43
Heavy metals intoxication 
Heavy metals exposure is referred as a risk
factor for the development of ALS.37 Kamel et
al.45 conducted a study to investigate the asso-
ciation of lead exposure with ALS appearance,
using questionnaires and biological markers.
A higher risk related to the report of occupa-
tional exposure to lead was observed, and not
to a home and/or recreative exposure. An asso-
ciation with high levels of blood or bone lead
was also observed. Oh et al.46 described the
case of an ALS patient who worked in an elec-
tronic  components  factory  with  evidence  of
excessive acute exposure to lead. The study
concluded that, although no other assessments
were  performed  (genetic,  environmental  or
biologic), the probable etiology for ALS in this
case was exposure to lead. Similarly, acute and
chronic intoxication with mercury may cause
ALS  syndrome.  Some  authors  propose  that
many ALS patients report a previous exposure
to mercury.11 Schwarz et al.47 report a case in
which a nurse developed ALS after an accident
with mercury. The mercury thermometer was
broken  while  being  held  by  the  nurse,  with
resulting mercury infiltration in her skin, hin-
dering the complete surgical removal of all the
particles. Three and a half years later, the 38-
year-old  patient  started  to  present  a  pro-
nounced weakness in the lower limbs, cerebel-
lar  ataxia,  fasciculation,  hyperreflexia  and
Babinski sign. She was diagnosed with ALS,
possibly explained by the slow accumulation of
mercury in the SNC, since the multiple trau-
mas  resulting  from  the  surgery  may  have
favored  retrograde  axonal  transportation.
Recent studies suggest that copper deficiency
syndrome should be included in the motor neu-
ron  diseases.  Weihl  et  al.48 reported  three
cases of patients who presented copper defi-
ciency and clinical findings of ALS including
muscular  atrophy  and  weakness  and  elec-
tromyographic signals of denervation and had
no  ALS  diagnosis,  due  to  the  presence  of  a
hypoesthesia. Excessive exposure to selenium
(Se) has also been reported among the possi-
ble etiologies for ALS, with its unknown origin
and indicative of severe prognosis. This rela-
tion has been based on epidemiological inves-
tigations  which  demonstrate  an  increase  of
ALS risk associated with the residency in a Se-
impregnated area or with the consumption of
water with high inorganic levels of this metal.
Researches  in  animals  have  shown  that  Se,
mainly in its inorganic form, presents a selec-
tive toxicity to motor neurons, with the com-
promise of muscular function.49
Viral Infections 
Persistent viral infections were also pointed
as a predisposing factor for the development of
ALS.1 The persistent infection by enterovirus
has  been  reported  as  causing  sporadic  ALS,
given the poliovirus’s tropism by motor neu-
rons.  These  infections  are  lyseless and  non
cytopathic.50,51 Some viral properties, suscepti-
bility factors of the host and the time of expo-
sure may be important factors for the estab-
lishment of the infection. Tropism for motor
neurons, controlled by the conformation of the
viral capsid and surface receptors of the host
cell, guarantees that the infection select the
motor neurons and remain isolated. The infec-
tion may have access through the hemato-cel-
lular  barrier.  Once  inside,  it  contiguously
spreads.  Horizontal  propagation  includes
crossing  the  middle  line  of  the  encephalic
trunk or the spinal marrow, due to the seeming
proximity of the anterior horns and encephalic
trunk  nuclei.  Vertical  propagation  or  trans-
synaptic propagation provokes a leap between
lower  and  higher  motor  neurons,  the  latter
leading to long distance propagations. Because
the  infection  is  persistent  and  propagation
through motor system is successive, progres-
sion is linear instead of accelerated. Due to the
variation  of  biologic  factors,  such  as  vital
charge, virulence, and host cell factors, pro-
gression  rates  are  highly  variable  among
patients. Since the infection propagates, apop-
tosis  starts,  a  well  established  capacity  in
motor neurons known for its complex interac-
tion with viruses. Given the motor neurons’
limitation in number and their incapacity of
division, cellular death is accumulated, clini-
cally manifesting progressive weakness, which
starts in a centralized manner, spreads itself
and linearly progresses.50 Studies demonstrat-
ed a possible association between persistent
infection due to enterovirus and ALS develop-
ment in 46 individuals. They concluded that
the rate of 88.3% of nucleic acid detection of
the  enterovirus  in  the  neuron’s  body  of  the
spinal  marrow  in  ALS  patients  suggests  a
strong association between both conditions.52
Some retroviruses were also described in asso-
ciation with ALS-like syndromes, since motor
neurons’ syndromes may be associated with
HIV and HTLV-1, retroviruses subtypes.51 HIV
is not a neurotropic virus. It rarely infects neu-
rons, but emerges predominantly in microglias
of the central nervous system. Thus, selective
damages may occur to motor neurons by neu-
rotoxic viral proteins or cytokines (e.g., COX-
215)  and  chemokines  produced  as  a  conse-
quence  of  the  viral  infection.53 Zoccolella  et
al.54 reported a case of a 44-year-old man who
developed ALS concomitantly to the diagnosis
of HIV infection. The patient presented a dras-
tic reduction in plasmatic levels of HIV-RNA,
which could suggest the association of both
conditions.  However,  the  authors  highlight
that  the  association  of  HIV  infection  with
motor neuron diseases is rare, and ALS retro-
viral pathogenesis is not well defined. Verma et
al.51 described  two  cases  of  ALS  in  patients
with HIV infection. Both diagnosed the infec-
tion  and  further  presented  weakness  in  the
bulbar musculature and limbs. On the other
hand, the authors demonstrated that in this
type of association the disease varied in cer-
tain aspects in relation to those observed in
the classical form: patients are younger, there
was  no  inexorable  progression,  it  decreased
after the institution of antiviral therapy and
there was evidence of inflammatory response
in the central nervous system. Finally, a new
Article
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al.,55 who described the case of a patient with
a history of 9 years of hepatitis C, with progres-
sive weakness and right arm atrophy. No other
case of HCV infection and ALS was reported,
but further investigation is necessary, because
it can be a new possible association.
Physical activities 
Studies  with  workers  and  former  athletes
who developed ALS associated the history of
physical activity to the emergence of the dis-
ease, suggesting the hypothesis that vigorous
physical activity may be a predisposing factor
for developing the disease.56 This is justified
by the fact that physical practice leads to an
increase in oxidative stress or by an excitotox-
icity by glutamate. Physical activity may alter
the  balance  between  the  formation  and
removal of free radicals, leading to oxidative
stress,  in  addition  to  possibly  leading  to  an
overstimulation of motor neurons, with result-
ing  neuronal  death.57 A  study  performed  by
Longstreth Jr et al.58 aimed at assessing the
association  between  the  history  of  physical
activity and ALS diagnosis. The subjects were
submitted to an interview containing informa-
tion on physical activity performed before the
ALS diagnosis, during work or performed dur-
ing  free  time.  The  authors  concluded  that
physical activity does not seem to be a signifi-
cant risk factor for ALS, but they highlight the
necessity of more studies on the field for a bet-
ter preventive approach in patients with this
disorder.  Veldink et al.57 conducted a study
with the objective of assessing whether physi-
cal activity during work or free time is associ-
ated with the increase in the risk of developing
ALS and determining the association between
physical  activity  and  the  duration  or  age  of
onset  of  the  disease.  Questionnaires  were
applied in order to identify individual charac-
teristics,  including  anthropometric  features,
sex and age, and on the activity performed. In
conclusion, no strong association between the
practice  of  physical  activity  and  the  risk  of
developing  ALS  was  identified,  since  the
effects of the activity on the disease were not
totally clarified. Soccer is frequently associated
with ALS. Wicks et al.59 reported 3 cases of soc-
cer players who developed the disease simulta-
neously. The three patients started to present
the symptoms around the 50 years of age, but
in different segments (left foot, right leg and
higher left limb). All of them performed anoth-
er  kind  of  occupational  activity  including
chemical exposure, as electrician or engineer.
Two athletes had a previous history of smok-
ing, and they were all alcohol drinkers. The
three  players  played  soccer  for  at  least  10
years, and only one reported to usually head
the  ball.  The  authors  highlighted  that,
although  it  seems  a  coincidence,  these  ath-
letes presented similar clinical histories, being
exposed to the same risk factors. However, for
this reason, it cannot be concluded that these
cases are due only to soccer playing, but that it
is strongly associated to the development of
this morbidity. Some explanations for this fact
include the habit of heading the ball and the
use of pesticides in the field.
Conclusion 
From what was exposed, it can be perceived
that there is still no consensus on ALS’s etiolo-
gy. Researches show evidence of intoxication
by heavy metals, environmental and occupa-
tional causes, genetic mutations (superoxide
dismutase 1), certain viral infections and the
performance of rigorous physical activity for
the development of the disease. Due to this
great diversity of possible causing agents for
ALS, new researches are necessary to eluci-
date possible etiologies for a better approach to
the patients, promoting preventive programs
for  the  disease,  optimizing  functions  and
improving the life quality of the patients.
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